Perinatal Biology Symposium 2019

Perinatal Exposures: Intersecting Mechanisms leading to Developmental Outcomes

Abstract Submission Deadline was May 15, 2019

Consideration for Travel Awards and inclusion on the Program Booklet closed May 15, 2019

Conference Presentation Only closes August 1, 2019

All abstracts submitted by the deadline (May 15th, 2019) and accepted for presentation at the conference will be published in the Conference Proceedings Booklet, but not be publicly-accessible – this is meant to ensure that attendees will be able to submit their latest work, controversial observations, etc. Abstracts submitted after the May 15th deadline may be considered for presentation at the conference at the discretion of the selection committee but will not be published in the Conference Proceedings Booklet.

Trainees and Early Investigators (defined below) who submit an abstracts for presentation at the meeting by the May 15th, 2019, deadline are eligible for Travel Awards that will be awarded competitively upon review of abstracts for scientific merit. Lodging and travel not covered by these awards will be the responsibility of the recipient.

Travel Awards

While anyone may submit an abstract for presentation at the meeting and publication, only Trainees and Early Investigators are eligible for Travel Awards. Trainees and Early Investigators are defined, respectively, as individuals still in full time training (PhD or MD; Medical Fellows or Residents; Post- doctoral Fellows) or researchers in a faculty or equivalent position within 6 years of their terminal degree (PhD or MD). To be eligible for a Travel Award an abstract must be submitted for presentation, and the awardee must be the presenting (first) author. The abstracts will be judged for scientific merit by the Scientific Committee and awards made.

Women and minorities are especially encouraged to apply for these awards

To apply for a Travel Award:

At the time you submit an abstract, please indicate in the email that you would like to apply for a Travel Award and whether you are a Trainee or an Early Investigator (see definitions above).

Also attach a letter in pdf format from the head of your department or you PI verifying your status as a Trainee or Early Investigator to your email submission with the abstract. Successful applicants will be notified by June 30th, 2019. Funds will be disbursed following the meeting upon receipt of documentation of expenses.

Please also provide an answer to the following three questions in the body of your email submission:

  • Race/Ethnicity as defined as an Underrepresented Minority by the NIH:
    • American Indian or Alaska Native
    • Black or African American
    • Hispanic or Latino
    • Native Hawaiian or other Pacific Islander
    • White or Caucasian
    • Other (Please Specify)
    • Prefer not to Answer
  • Gender
    • Female
    • Male
    • Prefer not to Answer
  • Disability Status
    • Disabled
    • Not Disabled
    • Prefer not to Answer

Abstract Instructions – Please adhere to the following guidelines when submitting your abstract. Prepare your abstract in your word processing program and send the abstract file as a Word document by email to: larry.reynolds@ndsu.edu, and Cc to: stephanie.wesolowski@ucdenver.edu; be sure to attach a letter in pdf format from the head of your department or you PI verifying your status as a Trainee or Early Investigator. We will send you confirmation or receipt within 3 business days. If you do not receive confirmation, please contact us.

  • Preparation of Abstract:
    • The abstract should be written in English and should be no longer than 350 words including title, authors, addresses, etc., and should be prepared using Microsoft Word.
    • Use both upper and lower case letters throughout the form – Do not use all caps or all lower case.
    • Special formatting (i.e. bold, bullets, italic, subscript etc.) and special characters are allowed.
    • The Word document should include the following items only in this order: Abstract Title, AuthorsNames and Affiliations, and Abstract Main Text (see Sample Abstract, next page).
    • Abstract Title: The abstract title should be listed on the first line and as concise as possible.
    • Authors names and affiliations should be listed in the next line.
      • Authors' names should be listed with initials of first names followed by the last names in full.Authors should be separated by commas and a period following the last name. The presenting author should be listed first.
      • Affiliations should follow the authors' names. For each affiliation list institution, city, state and country. Full street addresses and post codes/zip codes should not be included.
      • Numbers should be used as a key to couple names with affiliations. Numbers should appear before the authors' names and before each affiliation.
    • Abstract Main Text:
      • Leave a blank line before the main abstract text. Do not type "abstract" at the start of the main text.
      • Justify paragraphs and do not indent the first line of a paragraph.
      • Figures and tables must not be included in the abstracts.
      • Please define abbreviations at the first occurrence and avoid using them in the title where possible.
      • Abstracts should be structured and contain:
        • An initial statement of specific objectives of the study, unless this is given in the title.
        • A brief statement of methods.
        • A summary of the results obtained, including statistics (means, measure(s) of variation, P-levels).
        • Specific conclusions
        • Funding source(s) should be listed last in parenthesis.
      • Do not include non-specific statements such as ''The results will be discussed.

Sample Abstract:

Proliferative potential and apoptosis of human placental trophoblast over the course of pregnancy. 1T Maruo, 1H Matsuo, 2T Samoto, and 2N Ishari. 1Department of Ob/Gyn, Kobe Univ. School of Medicine, Kobe, Japan, 2Department of Fetal Development, Kawasaki Medical School, Kurashiki, Japan.

Objectives: To elucidate the regulation of human placental growth, we have determined the expression of proliferating cell nuclear antigen (PCNA), apoptotic DNA fragmentation, and bcl-2 protein in human placenta over the course of pregnancy. Methods: Brief statement of methods. Results: Summary of results obtained including statistics (means, measure(s) of variation, P-levels). Conclusions: Specific statement of conclusion(s). (Supported by NIH Grant AB12356).

  • Notification of Abstract Status:
    For abstracts submitted by May 15th, 2019, you will receive notification of abstract acceptance and Travel Award decision, together with instructions for presentation by June 30, 2019, via email. For abstracts submitted after May 15th, 2019, and before August 1st, 2019 which will being considered for abstract presentation at the conference only, you will be notified of acceptance by August 15th, 2019.In case of difficulties with preparation or submission of the abstract or for any other information please contact:Please submit abstracts (and related materials if applying for a Travel Award) to: larry.reynolds@ndsu.edu, and Cc to: stephanie.wesolowski@ucdenver.edu.

Become an ASAS member

Membership is open to individuals, organizations, or firms interested in research and application, instruction, or extension in animal science or associated with the production, processing, marketing, or distribution of livestock and livestock products.

Learn More

Enter your search terms below